A detailed history of Kent Lake Capital LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Kent Lake Capital LLC holds 1,144,254 shares of NPCE stock, worth $10.6 Million. This represents 3.99% of its overall portfolio holdings.

Number of Shares
1,144,254
Previous 643,629 77.78%
Holding current value
$10.6 Million
Previous $8.5 Million 1.82%
% of portfolio
3.99%
Previous 4.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.38 - $15.33 $3.19 Million - $7.67 Million
500,625 Added 77.78%
1,144,254 $8.65 Million
Q1 2024

May 15, 2024

SELL
$9.78 - $17.5 $267,160 - $478,047
-27,317 Reduced 4.07%
643,629 $8.5 Million
Q4 2023

Feb 14, 2024

BUY
$5.9 - $10.31 $3.08 Million - $5.38 Million
521,741 Added 349.68%
670,946 $6.92 Million
Q2 2023

Aug 14, 2023

BUY
$3.98 - $5.12 $85,685 - $110,228
21,529 Added 16.86%
149,205 $669,000
Q1 2023

May 15, 2023

BUY
$1.44 - $5.34 $183,853 - $681,789
127,676 New
127,676 $592,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $230M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Kent Lake Capital LLC Portfolio

Follow Kent Lake Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kent Lake Capital LLC with notifications on news.